对Scytophycin B的结构-活性关系研究,这是一种含有螺旋环氧化物的细胞毒性宏化物
Takayuki Ohyoshi1, Mayu Namiki1, Shusei Sato1
1Department of Chemistry, Faculty of Pure and Applied Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8571, Japan.
Organic letters
|November 11, 2024
概括
研究人员合成了强有力的细胞毒剂 - - 细胞毒素B的碎片. 单独的麦克罗拉克和侧链碎片都没有显著的细胞毒性,这突显了完整的B细胞毒素结构对其活性的重要性.
科学领域:
- 有机合成 有机合成
- 自然产品化学 自然产品化学
- 化学生物学是化学生物学.
背景情况:
- 细胞毒素B是一种具有复杂结构的强有力的细胞毒性天然产品.
- 对于药物开发来说,了解B细胞核素的结构-活性关系至关重要.
- 之前的研究主要集中在囊素B的总合成上.
研究的目的:
- 为了合成麦克罗拉克和侧链碎片的B. 细胞毒素.
- 评估这些个体碎片的生物活性,特别是细胞毒性.
- 阐明每个片段对B细胞毒素B的总体细胞毒性的贡献.
主要方法:
- 使用通过交叉转移的二元化方法合成巨乳素片段.
- 侧链片段的合成,采用Sharpless环氧化后期功能化.
- 在实验室中评估合成碎片和B细胞毒素B的细胞毒性活性.
主要成果:
- 成功合成了麦克罗拉克和侧链片段的B型细胞素B.
- 合成的碎片显示出与原始化合物 - - 赛托菲辛B相比显著较弱的细胞毒性.
- 碎片活动的减少表明,在完整的分子内有协同效应.
结论:
- 赛托菲辛B的完整分子结构对于其强大的细胞毒性活性至关重要.
- 结构-活性关系研究表明,麦克罗拉克和侧链对疗效至关重要.
- 这项研究为设计基于细胞毒素B支架的新型细胞毒剂提供了宝贵的见解.
更多相关视频
07:50Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
1.6K
09:09High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
Published on: November 16, 2016
7.9K
相关概念视频
Structure-Activity Relationships and Drug Design
597
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
597
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
2.6K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.6K
